Briefings in Bioinformatics, 2025 Correction to: Synthetic plasma pool cohort correction for affinity-based proteomics datasets allows multiple study comparison Olink Target 96Wider Proteomics StudiesData SciencePlasma | | | | |
Nature, 2025 Translational genomics of osteoarthritis in 1,962,069 individuals Hatzikotoulas K., Southam L., Stefansdottir L. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Physiological Genomics, 2025 The Acute Effects of Neuromuscular Electrical Stimulation on Coagulation and Cardiovascular Factors Flodin J., Reitzner S., Mahmoud Hourani Soutari N. et al. Olink Target 96CVDHematologyPathophysiologyPlasma | | | | |
Cell Host & Microbe, 2025 Antibiotic-induced gut microbiome perturbation alters the immune responses to the rabies vaccine Feng Y., de Jong S., Oliveira A. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Thrombosis Journal, 2025 Association of MTHFR missense variants with thromboembolic diseases and coagulation factor levels in European populations Daghlas I., Wang M., Gill D. Olink Explore 3072/384CVDHematologyPathophysiologyPlasma | | | | |
npj Precision Oncology, 2025 Plasma proteomic biomarkers predict therapeutic responses in advanced biliary tract cancer patients receiving Camrelizumab plus the GEMOX treatment Cui S., Zheng H., Xu Y. et al. Olink Target 96OncologyImmunotherapyPatient StratificationPlasma | | | | |
Scandinavian Journal of Gastroenterology, 2025 Proteomic signatures for fibrosis in MASLD: a biopsy-proven dual-cohort study Blomdahl J., Åberg M., Fridén M. et al. Olink Target 96Metabolic DiseasesHepatologyPatient StratificationPlasma | | | | |
International Journal of Cardiology Congenital Heart Disease, 2025 Correlation between Olink and SomaScan proteomics platforms in adults with a Fontan circulation Assi I., Landzberg M., Becker K. et al. Olink Target 96CVDCross-platform ValidationPlasma | | | | |
American Journal of Respiratory and Critical Care Medicine, 2025 Proteomic Biomarkers of Survival in Non-IPF Interstitial Lung Disease Alqalyoobi S., Smith J., Maddali M. et al. Olink Explore 3072/384Respiratory DiseasesPathophysiologyPatient StratificationPlasma | | | | |
Discover Oncology, 2025 Appraising the causal role of cathepsins in genitourinary carcinoma: a two-sample mendelian randomization and prospective study based on 36,225 individuals Zhu Q., Liu D., Liu H. et al. Olink Explore 3072/384OncologyPathophysiologyPlasma | | | | |
CNS Neuroscience & Therapeutics, 2025 The Association of Serum Biomarkers With Symptomatic Hemorrhagic Transformation in Acute Ischemic Stroke Patients: A Combined Retrospective and Prospective Study Yuan S., Gao D., Shi W. et al. Olink Target 96NeurologyPatient StratificationSerum | | | | |
Proceedings of the National Academy of Sciences, 2025 Nuclear Galectin-1 promotes
KRAS
-dependent activation of pancreatic cancer stellate cells Vinaixa J., Martínez-Bosch N., Gibert J. et al. Olink Target 96OncologyPathophysiologyCell Culture Supernatant | | | | |
Liver International Communications, 2025 Extracellular Cathepsin B Is a Potential Therapeutic Target in Hepatocellular Carcinoma van Mourik H., Westheim A., Schneider C. et al. Olink Explore 3072/384OncologyPathophysiologyPlasma | | | | |
International Journal of Molecular Sciences, 2025 The Presence of Adipose Tissue in Aortic Valves Influences Inflammation and Extracellular Matrix Composition in Chronic Aortic Regurgitation Sádaba A., Garaikoetxea M., Tiraplegui C. et al. Olink Target 96CVDPathophysiologyTissue Lysate | | | | |
Brain, Behavior, and Immunity, 2025 CCL25 in the cerebrospinal fluid is negatively correlated with fatigue in chronic pain patients Rosenström A., Ahmed A., Farinotti A. et al. Olink Target 96NeurologyPathophysiologyPatient StratificationPlasmaCSF | | | | |
Clinical Chemistry, 2025 Correlations Within and Between Highly Multiplexed Proteomic Assays of Human Plasma Rooney M., Chen J., Ballantyne C. et al. Olink Explore HTWider Proteomics StudiesTechnical EvaluationPlasma | | | | |
Cell Reports Medicine, 2025 TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors Plummer R., Sodergren M., Hodgson R. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPlasma | | | | |
Journal of Virology, 2025 Development and optimization of human T-cell leukemia virus-specific antibody-dependent cell-mediated cytotoxicity (ADCC) assay directed to the envelope protein Pise-Masison C., Rahman M., Masison D. et al. Olink Target 48Infectious DiseasesTechnical EvaluationPrimate Plasma | | | | |
BMC Medical Genomics, 2025 Causal association between non-steroidal anti-inflammatory drugs use and the risk of benign prostatic hyperplasia: a univariable and multivariable Mendelian randomization study Peng Z., Li M., He M. et al. Olink Target 96Other Diseases & SyndromesPathophysiologyPlasma | | | | |
Clinical and Translational Medicine, 2025 Sendotypes predict worsening renal function in chronic kidney disease patients McLarnon T., Watterson S., McCallion S. et al. Olink Target 96NephrologyAgingPatient StratificationPlasma | | | | |